not sure what you mean by " could see these pump and dump clearly", I made my money by finding my biotech gems and sticking with them for several years, I am not good at and I don't believe in day trading or swing trading, to me this is waste of time, on paper trading volatility sounds great but in reality almost nobody can predict those random moves in small biotech stocks
yeah, the last two days trading action was very unexpected, just like about everything about this stock you just never know what happens tomorrow, interestingly shorts are still staying away from this stock
café, to lose 300K on 30% drop you have to have 1M in this stock, are you out of your mind? who the heck invests 1M in single drug company when that single drug is just iron pill and it's run by the worst management on the block, I wish you would have ask for advise sooner
Kerx valuation right now is just ~500M, selling right now means you expect total disaster like there are fundamental manufacturing issues making Auryxia mass production close to impossible, we know that's not the case, I can't justify selling shares for $4.50, shares still may go lower, who knows, but if you have 12-24months horizon I am pretty sure we will see double digits on the stock price
SNY looking for bigger deal, the word on the street is disappointed SNY will now go after BMRN, buying Kerx will cut in to Renvela profits, not sure it makes big business sense for SNY to sell two competing binders
I been pumping these three stocks for 6months now, this trio will go next after MDVN, buy, buy, buy and forget about Kerx for now, nothing to discuss or see here until more news emerges
you got to be kidding me, who you think spends all day on message board without even holding any stock? a person with zero life, I bet the guy barely has money to buy a sandwich
he is not dumb, he is just very lonely, he knows zero about biotech, or Kerx, just spending all day Googling shiat and posting irrelevant generalities...
part of me still believes that something good is going on behind the scenes, but what's on the surface is ugly, time to take a break from markets in my opinion, enjoy last two weeks of the summer
looks like someone bought shares today:), honestly, I am surprised the stock is not at $3, not much uptick in sales after 18months since launch, and now it appears they can't even control manufacturing cycle, I mean how much worse can it get? thankfully it is just an iron pill and people can't die from side effects
I don't think Patent announcement can move the stock much, maybe 5%? IP is not an overhang for the stock, sales are, however I agree that not announcing the new patent is highly unusual, I am done over analyzing this company, I cut my stake in half and intend to ride out this story till the end with remaining shares
when your sales are next to zero for over a year I would think manufacturer has very little incentive to pay much attention to the production cycle, I don't know what's going on, but if I was running manufacturing plant I don't want to waste my time on pills that generate just 500 scripts per week...
there is nothing to rebut because you always post irrelevant info, my point is dummy that RLYP was sold for very cheap and it was sold for cheap because ZS-9 and because they don't own EU rights, who owns EU rights is irrelevant here just like your every post, as for medical opinions I am not even going there, that would be like discussing rocket science with my dog, all you do is copy paste irrelevant #$%$ and dying for people to engage you so you have something to spend your day on...get a life
haha, hey dummy glad you learned how to spell "medical opinion", you are biggest idiot this board has seen, I figured that last November, I wish you knew how irrelevant your every post is, internet virus is what you are...waste of time
when you consider cash in hand that RLYP had and tax break that Galenica gets then you would realize that RLYP was sold for pennies, you know why? because ZS-9 is technically better drug and although approval is delayed, still in 18months the drug will hit the market, also lack of EU rights cuts the price tag in half, not sure how this is relevant to Kerx but our resident troll thinks that yahoo is THE place where lonely people get together and post all sorts of things
I think Novartis is the leader in bone cancer treatments, I know drug Gleevec is used a lot, then there is newer drug Panobinostat also marketed by Novartis, unfortunately I haven't heard of any major break through in bone cancer treatment though, still the best chance is surgery assuming they caught it in time, however if you want to know about the best drug combination treatment I would call Novartis and get latest update as well as info on on-going trials,
best of luck to your friend!